Ovarian cancer doxorubicin. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy9

Cell Line, Tumor Tumor Cells, Cultured Ovary Neoplastic Stem Cells Epithelial Cells Spheroids, Cellular MCF-7 Cells Breast Cell Line

Organisms3

Mice, Nude Mice, SCID Mice, Inbred BALB C

Diseases52

Ovarian Neoplasms Neoplasms, Glandular and Epithelial Cystadenocarcinoma, Serous Breast Neoplasms Carcinoma Neoplasm Invasiveness Adenocarcinoma, Clear Cell Neoplasm Metastasis Lung Neoplasms Neoplasms Carcinoma, Endometrioid Peritoneal Neoplasms Prostatic Neoplasms Colonic Neoplasms Adenocarcinoma, Mucinous Genetic Predisposition to Disease Ascites Neoplasm Recurrence, Local Disease Progression Stomach Neoplasms Endometrial Neoplasms Cystadenocarcinoma Pancreatic Neoplasms Fallopian Tube Neoplasms Adenocarcinoma Genital Neoplasms, Female Uterine Cervical Neoplasms Neoplasms, Cystic, Mucinous, and Serous Urinary Bladder Neoplasms Neoplastic Syndromes, Hereditary Carcinoma, Squamous Cell Colorectal Neoplasms Cell Transformation, Neoplastic Hereditary Breast and Ovarian Cancer Syndrome Neovascularization, Pathologic Carcinoma, Non-Small-Cell Lung Bone Neoplasms Cystadenocarcinoma, Mucinous Carcinoma, Small Cell Liver Neoplasms Sarcoma Neutropenia Cystadenoma, Serous Leukemia P388 Disease Models, Animal Rectal Neoplasms Neoplasms, Second Primary Adenocarcinoma, Papillary Neoplasms, Experimental Nausea Breast Neoplasms, Male Head and Neck Neoplasms

Chemicals and Drugs75

Doxorubicin Antibiotics, Antineoplastic CA-125 Antigen Antineoplastic Agents Paclitaxel Cisplatin Cyclophosphamide Tumor Markers, Biological Vincristine Neoplasm Proteins Antineoplastic Agents, Phytogenic BRCA2 Protein Razoxane BRCA1 Protein Carboplatin P-Glycoprotein Drug Carriers RNA, Messenger RNA, Small Interfering Liposomes DNA, Neoplasm Tumor Suppressor Protein p53 Polyethylene Glycols Epididymal Secretory Proteins Taxoids Etoposide Receptor, erbB-2 Cancer Vaccines Antigens, Neoplasm Vinblastine Fluorouracil Antibodies, Monoclonal Platinum Compounds Platinum Topotecan Prednisone Receptors, Estrogen Deoxycytidine Anthracyclines RNA, Neoplasm Daunorubicin Tamoxifen DNA-Binding Proteins Organoplatinum Compounds Altretamine Proto-Oncogene Proteins c-akt Transcription Factors Mitoxantrone Tumor Suppressor Proteins Ifosfamide Antibodies, Monoclonal, Humanized MicroRNAs Antigens, Tumor-Associated, Carbohydrate Bleomycin Receptors, Progesterone Methotrexate Epirubicin Receptor, Epidermal Growth Factor Cardiotoxins Proto-Oncogene Proteins Nuclear Proteins Antimetabolites, Antineoplastic Bridged Compounds Proto-Oncogene Proteins c-bcl-2 Hydroxyethylrutoside Antineoplastic Agents, Hormonal Prodrugs Prostate-Specific Antigen Contraceptives, Oral Caspase 3 Antibodies, Neoplasm Protein Kinase Inhibitors Apoptosis Regulatory Proteins Enzyme Inhibitors Folate Receptor 1

Analytical, Diagnostic and Therapeutic Techniques and Equipment62

Antineoplastic Combined Chemotherapy Protocols Early Detection of Cancer Neoplasm Staging Survival Analysis Prognosis Xenograft Model Antitumor Assays Disease-Free Survival Survival Rate Combined Modality Therapy Reverse Transcriptase Polymerase Chain Reaction Drug Administration Schedule Drug Screening Assays, Antitumor Treatment Outcome Neoplasm Transplantation Drug Carriers Gene Expression Profiling Blotting, Western Prospective Studies Transplantation, Heterologous Follow-Up Studies Risk Factors Risk Chemotherapy, Adjuvant Retrospective Studies Immunohistochemistry Drug Delivery Systems Kaplan-Meier Estimate Oligonucleotide Array Sequence Analysis Genetic Testing Risk Assessment Sensitivity and Specificity Odds Ratio Infusions, Intravenous Transfection Tumor Burden Registries Flow Cytometry Tissue Array Analysis Multivariate Analysis Clinical Trials as Topic Neoplasm Grading Inhibitory Concentration 50 Polymerase Chain Reaction Case-Control Studies Molecular Targeted Therapy Gene Knockdown Techniques Predictive Value of Tests Incidence DNA Mutational Analysis Confidence Intervals Reproducibility of Results Logistic Models Immunoenzyme Techniques Questionnaires Cohort Studies Disease Models, Animal Models, Biological SEER Program Salpingectomy Genetic Therapy Neoplasms, Experimental Immunotherapy

Psychiatry and Psychology1

Phenomena and Processes48

Drug Resistance, Neoplasm Genes, BRCA1 Gene Expression Regulation, Neoplastic Genes, BRCA2 Apoptosis Cell Survival Dose-Response Relationship, Drug Genetic Predisposition to Disease Cell Proliferation Drug Synergism Mutation Drug Resistance, Multiple Germ-Line Mutation Risk Cell Cycle Cell Division DNA Methylation Signal Transduction Down-Regulation Sensitivity and Specificity Time Factors Odds Ratio Transfection Cell Movement Up-Regulation Cell Growth Processes Genotype RNA Interference Drug Resistance Gene Silencing Inhibitory Concentration 50 Gene Expression Promoter Regions, Genetic Genes, Tumor Suppressor DNA Damage Polymorphism, Genetic Genes, p53 Base Sequence Phosphorylation Heterozygote Phenotype Tissue Distribution Genes, Neoplasm Alleles Gene Amplification Tumor Microenvironment Postmenopause Loss of Heterozygosity

Disciplines and Occupations3

Immunohistochemistry Medical Oncology Genetic Counseling

Anthropology, Education, Sociology and Social Phenomena2

National Cancer Institute (U.S.)Quality of Life

Technology, Industry, Agriculture3

Liposomes Polyethylene Glycols Nanoparticles

Humanities1

Quality of Life

Information Science7

Survival Rate Registries Incidence Base Sequence Questionnaires SEER Program Molecular Sequence Data

Named Groups2

Health Care29

Survival Analysis Disease-Free Survival Survival Rate Treatment Outcome Prospective Studies Follow-Up Studies Risk Factors Risk Retrospective Studies Kaplan-Meier Estimate Genetic Testing Risk Assessment Sensitivity and Specificity Odds Ratio Age Factors Registries Multivariate Analysis Clinical Trials as Topic Case-Control Studies Predictive Value of Tests National Cancer Institute (U.S.)Incidence Confidence Intervals Reproducibility of Results Logistic Models Questionnaires Cohort Studies SEER Program Genetic Counseling

Geographicals1

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Phenomena and Processes Disciplines and Occupations Anthropology, Education, Sociology and Social Phenomena Technology, Industry, Agriculture Information Science Named Groups Health Care Geographicals

Doxorubicin Ovarian Neoplasms Neoplasms, Glandular and Epithelial Antibiotics, Antineoplastic Cell Line, Tumor CA-125 Antigen Antineoplastic Agents Cystadenocarcinoma, Serous Antineoplastic Combined Chemotherapy Protocols Drug Resistance, Neoplasm Breast Neoplasms Paclitaxel Cisplatin Genes, BRCA1 Early Detection of Cancer Gene Expression Regulation, Neoplastic Mice, Nude Carcinoma Neoplasm Staging Cyclophosphamide Survival Analysis Tumor Markers, Biological Neoplasm Invasiveness Prognosis Tumor Cells, Cultured Vincristine Xenograft Model Antitumor Assays Adenocarcinoma, Clear Cell Neoplasm Metastasis Genes, BRCA2 Neoplasm Proteins Lung Neoplasms Apoptosis Disease-Free Survival Survival Rate Neoplasms Carcinoma, Endometrioid Antineoplastic Agents, Phytogenic BRCA2 Protein Razoxane Peritoneal Neoplasms Prostatic Neoplasms BRCA1 Protein Cell Survival Combined Modality Therapy Dose-Response Relationship, Drug Colonic Neoplasms Adenocarcinoma, Mucinous Genetic Predisposition to Disease Reverse Transcriptase Polymerase Chain Reaction Drug Administration Schedule Cell Proliferation Carboplatin Ascites Drug Screening Assays, Antitumor Neoplasm Recurrence, Local Treatment Outcome Neoplasm Transplantation P-Glycoprotein Disease Progression Drug Carriers RNA, Messenger Gene Expression Profiling Drug Synergism Stomach Neoplasms Blotting, Western Mutation Endometrial Neoplasms RNA, Small Interfering Drug Resistance, Multiple Liposomes DNA, Neoplasm Tumor Suppressor Protein p53 Germ-Line Mutation Prospective Studies Polyethylene Glycols Transplantation, Heterologous Follow-Up Studies Risk Factors Epididymal Secretory Proteins Risk Cystadenocarcinoma Taxoids Chemotherapy, Adjuvant Etoposide Retrospective Studies Pancreatic Neoplasms Immunohistochemistry Fallopian Tube Neoplasms Receptor, erbB-2 Cancer Vaccines Antigens, Neoplasm Adenocarcinoma Vinblastine Ovary Fluorouracil Antibodies, Monoclonal Drug Delivery Systems Genital Neoplasms, Female Kaplan-Meier Estimate

No FAQ available that match "ovarian cancer doxorubicin"